Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny

Molecular Therapy

Volumn 6, Issue 5, 2002, Pages 673-677

  Amsellem, Sophie ^a   Ravet, Emmanuel ^a   Fichelson, Serge ^a   Pflumio, Françoise ^a   Dubart Kupperschmitt, Anne ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Cell therapy; Gene therapy; Gene transfer; Hematopoiesis; Hematopoietic stem cell; Lentiviral vector; Regulation

Indexed keywords

CD34 ANTIGEN; LENTIVIRUS VECTOR; REGULATOR PROTEIN; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL PROTOCOL; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROGENY; STEM CELL MOBILIZATION; TRANSGENE; UMBILICAL CORD BLOOD; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL SEPARATION; CYTOLOGY; FETUS BLOOD; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HEMATOPOIESIS; LENTIVIRINAE; METABOLISM; MOUSE; MOUSE MUTANT; POLYMERASE CHAIN REACTION;

LENTIVIRUS;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL SEPARATION; FETAL BLOOD; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; TRANSGENES;

EID: 0036853115     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(02)90718-5     Document Type: Article

References (24)

1. Orkin, S. H. (2000). Stem cell alchemy. Nat. Med. 6: 1212-1213.
2. Lowell, S. (2000) Stem cells show their potential. Trends Cell. Biol. 10: 210-211.
3. Wei, G., Schubiger, G., Harder, F., and Muller, A. M. (2000). Stem cell plasticity in mammals and transdetermination in Drosophila: Common themes? Stem Cells 18: 409-414.
4. Anderson, D. J., Gage, F. H., and Weissman, I. L. (2001). Can stem cells cross lineage boundaries? Nat. Med. 7: 393-395.
5. Blau, H. M., Brazelton, T. R., and Weimann, J. M. (2001). The evolving concept of a stem cell: Entity or function? Cell 105: 829-841.
6. Morrison, S. J. (2001) Stem cell potential: Can anything make anything? Curr. Biol. 11: R7-9.
7. Dorshkind, K. (2002). Multilineage development from adult bone marrow cells. Nat. Immunol. 3: 311-313.
8. Orkin, S. H., and Zon, L. I. (2002). Hematopoiesis and stem cells: Plasticity versus developmental heterogeneity. Nat. Immunol. 3: 323-328.
9. Terada, N., et al. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416: 542-545.
10. Ying, Q., Nichols, J., Evans, E., and Smith, A. (2002). Changing potency by spontaneous fusion. Nature 416: 545-548.
11. Sirven, A., et al. (2000). The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96: 4103-4110.
12. Sirven, A., et al. (2001). Enhanced transgene expression in cord blood cd34+-derived hematopoietic cells, including developing T cells and nod/scid mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther. 3: 438-448.
13. Lansdorp, P. M., Dragowska, W., and Mayani, H. (1993). Ontogeny-related changes in proliferative potential of human hematopoietic cells. J. Exp. Med. 178: 787-791.
14. Oh, I. H., Lau, A., and Eaves, C. J. (2000). During ontogeny primitive (CD34+CD38+) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. Blood 96: 4160-4168.
15. Avni, D., Shama, S., Loreni, F., and Meyuhas, O. (1994). Vertebrate mRNAs with a 5′-terminal pyrimidine tract are candidates for translational repression in quiescent cells: Characterization of the translational cis-regulatory element. Mol. Cell. Biol. 14: 3822-3833.
16. Piacibello, W., et al. (1997). Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89: 2644-2653.
17. Kobari, L., et al. (2000). In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34+ cord blood cells. Exp. Hematol. 28: 1470-1480.
18. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
19. Robin, C., Pflumio, F., Vainchenker, W., and Coulombel, L. (1999). Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in ther marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells. J. Exp. Med. 189: 1601-1610.
20. Cwirla, S. E., et al. (1997). Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 276: 1696-1699.
21. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum. Gene Ther. 9: 1497-1511.
22. ++/CD38 progenitor cells in long-term cultures and semisolid assays. Blood 81: 2916-2924.
23. Freyssinier, J. M., et al. (1999). Purification, amplification and characterization of a population of human erythroid progenitors. Br. J. Haematol. 106: 912-922.
24. + subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Br. J. Haematol. 104: 809-819.